Cytembena treatment of advances and relapsing uterine cervix carcinoma.
D000179:Acrylates / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D001966:Bromine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000179:Acrylates; D000970:Antineoplastic Agents; D001565:Benzoates; D001966:Bromine